Elesclomol (STA-4783) With Paclitaxel Versus Paclitaxel Alone in Melanoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00522834
Recruitment Status : Terminated
First Posted : August 30, 2007
Last Update Posted : March 4, 2014
Information provided by (Responsible Party):
Synta Pharmaceuticals Corp.